股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年3月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 草姬集團控股有限公司 呈交日期: 2026年4月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02593 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | FF301 II. ...

Financial Performance - Revenue decreased by approximately 7.2% from HKD 245.5 million in FY2024 to HKD 227.9 million in FY2025[2] - Gross profit fell by about 13.5% from HKD 182.1 million in FY2024 to HKD 157.5 million in FY2025, with a gross margin decline of 5.1 percentage points to 69.1%[2] - The company recorded a net loss of approximately HKD 23.0 million in FY2025, compared to a net profit of HKD 13.0 million in FY2024[2] - Total revenue from customer contracts was HKD 227,868,000 in 2025, down from HKD 245,490,000 in 2024, representing a decrease of about 7.1%[14] - The group reported a pre-tax loss of HKD 27,587,000 in 2025 compared to a profit of HKD 18,677,000 in 2024[24] - Basic earnings per share for 2025 were calculated based on a loss attributable to equity shareholders of HKD 23,009,000, compared to a profit of HKD 12,965,000 in 2024[25] - The group recorded a net loss of approximately HKD 23.0 million in fiscal year 2025, compared to a net profit of approximately HKD 13.0 million in fiscal year 2024, attributed to increased promotional offers and higher advertising and employee costs[72] Dividend Information - The board does not recommend the payment of a final dividend for FY2025, while a final dividend of HKD 20,000,040 was declared for FY2024[2] - No final dividend was proposed for 2025, while a final dividend of HKD 0.15 per share was declared for 2024, totaling HKD 20,000,000[28] - Cash dividends declared by a subsidiary amounted to HKD 30,000,000 for the year ended December 31, 2024[29] - The company approved a dividend of 15 HKD cents per share for the fiscal year 2025, totaling 20,000 thousand HKD, compared to no dividend in 2024[30] - The board of directors does not recommend the distribution of a final dividend for the reporting period, compared to a final dividend of HKD 20,000,040 in 2024[89] Asset and Liability Changes - Total assets decreased from HKD 197.5 million in FY2024 to HKD 159.9 million in FY2025, reflecting a decline in current assets[4] - Non-current assets decreased from HKD 44.5 million in FY2024 to HKD 34.3 million in FY2025, primarily due to a reduction in property and equipment[4] - The company's net asset value decreased from HKD 187.2 million in FY2024 to HKD 144.2 million in FY2025[5] - Cash and cash equivalents decreased significantly from HKD 119.2 million in FY2024 to HKD 78.2 million in FY2025[4] - Trade receivables decreased from 26,367 thousand HKD in 2024 to 24,187 thousand HKD in 2025, reflecting a decline of approximately 8.0%[31] - Trade payables increased from 3,782 thousand HKD in 2024 to 3,934 thousand HKD in 2025, representing a growth of approximately 4.0%[32] - Other payables and accrued expenses rose significantly from 15,350 thousand HKD in 2024 to 21,150 thousand HKD in 2025, marking an increase of about 37.5%[32] Revenue Breakdown - Customer contract revenue for retail business decreased to HKD 136,707,000 in 2025 from HKD 145,641,000 in 2024, a decline of approximately 6.4%[14] - Customer contract revenue for wholesale business decreased to HKD 87,619,000 in 2025 from HKD 94,157,000 in 2024, a decline of approximately 6.9%[14] - Revenue from retail business decreased by approximately HKD 8.9 million or 6.1%, from about HKD 145.6 million in FY2024 to approximately HKD 136.7 million in FY2025[62] - Revenue from wholesale business decreased by approximately HKD 6.6 million or 7.0%, from about HKD 94.2 million in FY2024 to approximately HKD 87.6 million in FY2025[63] - Revenue from consignment arrangements decreased by approximately HKD 2.2 million or 38.6%, from about HKD 5.7 million in FY2024 to approximately HKD 3.5 million in FY2025[64] Cost and Expense Changes - Employee costs rose to HKD 88,066,000 in 2025 from HKD 76,033,000 in 2024, an increase of about 15.8%[19] - Depreciation expenses increased to HKD 22,683,000 in 2025 from HKD 20,998,000 in 2024, an increase of approximately 8.0%[21] - Sales and distribution costs increased by approximately HKD 30.0 million or 28.4% in FY2025, primarily due to increased marketing and promotional expenses[67] - Administrative and other operating expenses increased by approximately HKD 12.1 million or 31.0% in FY2025, mainly due to higher employee costs and increased depreciation from more retail stores[68] - Financing costs decreased by approximately HKD 62,000 or 5.5% to about HKD 1,074,000 in the fiscal year 2025, primarily due to the absence of bank loan interest[70] Share Issuance and Capital Changes - The company issued 33,333,600 new ordinary shares at a cash price of 3.75 HKD per share, raising approximately 125,001 thousand HKD[34] - The share capital increased to 2,000,000,000 shares with a nominal value of 0.01 HKD per share as of December 31, 2024[33] - The company’s cash expenses related to share issuance were approximately 11,417 thousand HKD, which reduced the share premium generated from the issuance[34] Strategic Initiatives and Future Plans - The company plans to allocate approximately HKD 94.4 million from the net proceeds, with 35.7% (HKD 33.7 million) dedicated to marketing and promotional activities to enhance brand awareness by December 2027[85] - The company aims to expand and optimize its sales network, allocating 37.8% (HKD 35.7 million) of the proceeds for this purpose, with HKD 33.3 million expected to be utilized by December 2027[85] - The company is focusing on developing innovative packaging and expanding into new product categories, including Western health products and various external Chinese medicines[93] - The company plans to open new retail stores in selected locations to enhance customer accessibility and capture a larger market share[94] - The company will improve its online sales platform to better serve customers who prefer online shopping, capitalizing on the growing e-commerce demand in the health product sector[94] Governance and Compliance - The Audit Committee, composed of three independent non-executive directors, has reviewed and approved the consolidated financial statements for the reporting period[103] - The company's auditor, BDO Limited, confirmed that the financial data in the preliminary announcement is consistent with the amounts in the draft consolidated financial statements[104] - The company has adopted the standards set out in Appendix C3 of the Listing Rules as a code of conduct for directors' securities transactions[101] - Independent non-executive directors had opportunities to discuss governance and board matters during the reporting period[99] - The Board of Directors consists of both executive and independent non-executive directors, ensuring a balanced governance structure[107]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 Herbs Generation Group Holdings Limited 草姬集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：2593） 董事會會議日期 草 姬 集 團 控 股 有 限 公 司（「本公司」）董 事（「董 事」）會（「董事會」）謹 此 宣 佈，董 事 會 會 議 將 於 二 零 二 六 年 三 月 二 十 四 日（星 期 二）舉 行，藉 以（其 中 包 括）批 准 本 公 司 及 其 附 屬 公 司 截 至 二 零 二 五 年 十 二 月 三 十 一 日 止 年 度 之 業 績 公 告 及 其 發 佈， 以 及 考 慮 會 否 建 議 派 發 末 期 股 息（如 有）。 承董事會命 主 席 郭致因 香 港，二 零 二 六 年 三 月 十 日 於 本 公 告 日 期，董 事 會 由(i)執 行 董 事 郭 致 因 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 – 1 – 本 公 司 股 東 及 潛 在 投 資 者 於 買 賣 本 公 司 證 券 時 務 請 審 慎 行 事。 承董事會命 Herbs Generation Group Holdings Limited 草姬集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：2593） 盈利警告 本 公 告 乃 由 草 姬 集 團 控 股 有 限 公 司（「本公司」，連 同 其 附 屬 公 司 統 稱「本集團」） 根 據 香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則（「上市規則」）第13.09條及香港法例 第571章證券及期貨條例第XIVA部 之 內 幕 消 息 條 文（定 義 見 上 市 規 則）而 作 出。 本 公 司 董 事（「董 事」）會（「董事會」）謹 此 告 知 本 公 司 股 東 及 潛 在 投 資 者，根 據 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年2月28日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 草姬集團控股有限公司 呈交日期: 2026年3月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02593 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | 本月底法定/註冊股本 ...

呈交日期: 2026年2月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02593 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | 本月底法定/註冊股本總額： HKD 20,000,000 FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 草姬集團控股有限公司 呈交日期: 2026年1月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02593 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | 本月底法定/註冊股 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 致：香港交易及結算所有限公司 公司名稱: 草姬集團控股有限公司 呈交日期: 2025年12月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02593 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | 本月底法定/註冊股本總額： HKD 20,000,000 FF301 ...

Group 1 - The company announced the resignation of Ms. Chan Ai Ling as the company secretary and authorized representative, effective from November 7, 2025 [1] - Following Ms. Chan's resignation, Mr. Zeng Qingxuan has been appointed as the new company secretary and authorized representative, effective from November 7, 2025 [1]

Core Points - Grassland Group (02593.HK) announced the resignation of Chan Ai Ling as (i) company secretary; (ii) authorized representative under the Listing Rules of the Stock Exchange of Hong Kong Section 3.05; and (iii) legal representative for receiving legal documents and notifications in Hong Kong under the Companies Ordinance (Cap. 622) Section 16, effective from November 7, 2025 [1] - Following Chan Ai Ling's resignation, Zeng Qingxuan has been appointed as the company secretary and authorized representative, effective from November 7, 2025 [1] - Additionally, the executive director Li Risheng is now serving as the legal representative for the company [1]